U.S. Markets close in 5 hrs 56 mins
  • S&P 500

    +3.73 (+0.11%)
  • Dow 30

    -25.88 (-0.09%)
  • Nasdaq

    +60.84 (+0.54%)
  • Russell 2000

    -35.29 (-2.15%)
  • Crude Oil

    +0.39 (+1.01%)
  • Gold

    -1.20 (-0.06%)
  • Silver

    +0.02 (+0.08%)

    +0.0020 (+0.1657%)
  • 10-Yr Bond

    -0.0150 (-1.87%)
  • Vix

    +4.48 (+16.26%)

    +0.0017 (+0.1317%)

    -0.2050 (-0.1955%)

    +279.79 (+2.13%)
  • CMC Crypto 200

    +5.32 (+2.04%)
  • FTSE 100

    +11.56 (+0.20%)
  • Nikkei 225

    -8.54 (-0.04%)

BioUtah and the University of Utah’s Center for Technology & Venture Commercialization Announce Early Bird Registration for the 2020 Entrepreneur and Investor Summit

The 2020 Entrepreneur and Investor Summit, along with Title Sponsor, Simpson Thacher, will host the year’s premier gathering of Utah’s life sciences’ innovators and investors, featuring notable speakers, education sessions, and valuable networking opportunities.

BioUtah, Utah’s only trade association dedicated solely to the life sciences, in partnership with the University of Utah’s Center for Technology & Venture Commercialization (TVC), today announced that early bird registration is open for the 2020 Entrepreneur and Investor (E&I) Summit. The E&I Summit connects Utah life sciences entrepreneurs, as well as early and late-stage companies that are on the frontline of health innovation, with local and nationally recognized investors.

The conference will be held on February 28, 2020 at the University of Utah’s Cleone Peterson Eccles Alumni House and proudly sponsored by Simpson Thacher. Early bird discounts are available for both members and non-members who register by January 31. For sponsor and exhibitor information view the Sponsor and Exhibitor Prospectus.

The E&I Summit will host a notable group of speakers and panelists, including industry leaders, mentors, entrepreneurs, investors, economic analysts, and investment experts. The program will also provide opportunities for companies to engage directly with investors.

"We’re designing the agenda to put innovators directly in touch with key investors who can discuss financing options, and industry leaders who can share valuable lessons learned," said Kelvyn Cullimore, president and CEO of BioUtah. "Whether you’re looking for partners, funding, networking or expert advice, this is the place to be."

"The sessions will reflect the needs and diversity of Utah’s life sciences industry," said Keith Marmer, executive director and associate vice president of the TVC. "Our goal is to help move the dial in terms of access to investor capital and fostering an environment where new medical technologies and treatments can take root and succeed."

About BioUtah

BioUtah is an independent 501(c)(6) trade association serving Utah’s life sciences industry. Its member companies reflect a broad spectrum of the industry with strengths in medical device manufacturing and services, research and testing, biotechnology, biopharmaceuticals, and advanced diagnostics, amongst others; and are a key driver of Utah’s economy.

About the Center for Technology & Venture Commercialization

The Center for Technology & Venture Commercialization is dedicated to helping the University of Utah’s faculty inventors bring their innovations to market. TVC is responsible for all aspects of invention management, patent prosecution, licensing, startup formation and support, equity management and early-stage funding. The center’s mission is to expand the university’s reputation for innovation, and positively impact society. TVC is proud to help foster this spirit of discovery.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191211005282/en/


Denise Bell